B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC5A11

MOLECULAR TARGET

solute carrier family 5 member 11

UniProt: Q8WWX8NCBI Gene: 1155843 compounds

SLC5A11 (solute carrier family 5 member 11) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC5A11

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1dapagliflozin3.8345
2Inositol0.691
3phlorhizin0.691

About SLC5A11 as a Drug Target

SLC5A11 (solute carrier family 5 member 11) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented SLC5A11 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC5A11 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.